Global Research Antibodies Market to reach USD 4.6 billion by 2025.
Global Research Antibodies Market valued approximately USD 2.64 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6.30 % over the forecast period 2017-2025.
The market is predominantly driven by growing number of R&D collaborations among various public and private organizations to promote technical advancements in product development activities and disease progression studies. Consistent recommendations and guidelines issued by regulatory organizations for laboratories to facilitate generation of accurate results and ensure high-quality standards are slated to enhance adoption of research antibodies over the coming years. For instance, in May 2016, the International Society for Stem Cell Research issued revised guidelines for cell-based therapies. The revised guidelines were issued with a focus to improve overall efficiency and quality of preclinical studies
increasing prevalence of cancer and other chronic diseases is encouraging academic institutes as well as pharmaceutical and biotechnology companies to develop advanced generation therapeutics and personalized medicines. This is one of the key trends stimulating market growth. Usage of research antibodies in early detection of cancer has also been gaining recognition in the medical industry. Asia-Pacific and the increasing demand for personalized medicine and protein therapeutics are expected to offer significant growth opportunities for players in this market.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Reagents
  • Antibodies


By Technology:

  • Western Blotting
  • Flow Cytometry
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry
  • Immunofluorescence
  • Immunoprecipitation


By Application:

  • Proteomics
  • Drug Development
  • Genomics
  • Others


By End User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations


By Regions:

  • North America


o U.S.
o Canada

  • Europe


o UK
o Germany

  • Asia Pacific


o China
o India
o Japan

  • Latin America


o Brazil
o Mexico

  • Rest of the World



Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

The industry is seeming to be fairly competitive. Some of the leading market players include Merck Group, Abcam PLC, Becton, Dickinson and Company, Cell Signaling Technology, Inc, Bio-Rad Laboratories, Inc. , Lonza , Genscript , Biolegend, Inc., Danaher Corporation, Thermo Fisher Scientific Inc and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Research Antibodies Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors